From Chlamydomonas to Volvox: AI-Assisted Optogenetic Strategies for Investigating Neurodegenerative Disorders

Neurodegenerative disorders are characterized by progressive cellular dysfunction, aberrant synaptic signaling, protein aggregation, and neuronal loss. Dissecting the circuit-level changes preceding cell death requires tools that perturb defined cell populations with millisecond precision, which optogenetics provides. The technology rests on microbial opsins, beginning with the blue-light-gated channelrhodopsins of the green alga Chlamydomonas reinhardtii. Because blue light penetrates brain tissue poorly, attention turned to red-shifted channelrhodopsins from other algae. The colonial alga Volvox carteri supplied VChR1, the first naturally red-shifted template, which was recombined with Chlamydomonas sequences to build the chimeras C1V1 and ReaChR, while Chlamydomonas noctigama supplied the widely used red-light-driven opsin Chrimson. Machine learning has so far contributed mainly to expression and trafficking: Gaussian process models trained on chimeric libraries predicted membrane localization and yielded high-photocurrent variants such as ChRger2, optimizing expression rather than spectral tuning. Structure predictors and protein language models remain promising but unvalidated for opsin engineering in the studies reviewed here. This review traces this lineage, separates demonstrated machine-learning outcomes from proposals, and examines applications in Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and ALS. Most disease studies still rely on ChR2 or non-opsin light-sensitive proteins, red-shifted transcranial stimulation remains limited to rodents, and the long-term safety of expressing algal opsins in the human brain is unestablished. Keywords: Optogenetics; Channelrhodopsin; Chlamydomonas reinhardtii; Volvox carteri; Red-shifted opsins; Machine learning; Protein engineering; Neurodegenerative disorders.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24363181
Primary Topic
Photoreceptor and optogenetics research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

From Chlamydomonas to Volvox: AI-Assisted Optogenetic Strategies for Investigating Neurodegenerative Disorders

Tushar Ingle, Rohan Mane, Shubhangi Lal, Shital Revan Kalekar
Zenodo (CERN European Organization for Nuclear Research)
Photoreceptor and optogenetics research
article

From Chlamydomonas to Volvox: AI-Assisted Optogenetic Strategies for Investigating Neurodegenerative Disorders

Tushar Ingle, Rohan Mane, Shubhangi Lal, Shital Revan Kalekar
article en

Abstract

Neurodegenerative disorders are characterized by progressive cellular dysfunction, aberrant synaptic signaling, protein aggregation, and neuronal loss. Dissecting the circuit-level changes preceding cell death requires tools that perturb defined cell populations with millisecond precision, which optogenetics provides. The technology rests on microbial opsins, beginning with the blue-light-gated channelrhodopsins of the green alga Chlamydomonas reinhardtii. Because blue light penetrates brain tissue poorly, attention turned to red-shifted channelrhodopsins from other algae. The colonial alga Volvox carteri supplied VChR1, the first naturally red-shifted template, which was recombined with Chlamydomonas sequences to build the chimeras C1V1 and ReaChR, while Chlamydomonas noctigama supplied the widely used red-light-driven opsin Chrimson. Machine learning has so far contributed mainly to expression and trafficking: Gaussian process models trained on chimeric libraries predicted membrane localization and yielded high-photocurrent variants such as ChRger2, optimizing expression rather than spectral tuning. Structure predictors and protein language models remain promising but unvalidated for opsin engineering in the studies reviewed here. This review traces this lineage, separates demonstrated machine-learning outcomes from proposals, and examines applications in Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and ALS. Most disease studies still rely on ChR2 or non-opsin light-sensitive proteins, red-shifted transcranial stimulation remains limited to rodents, and the long-term safety of expressing algal opsins in the human brain is unestablished. Keywords: Optogenetics; Channelrhodopsin; Chlamydomonas reinhardtii; Volvox carteri; Red-shifted opsins; Machine learning; Protein engineering; Neurodegenerative disorders.

Zenodo (CERN European Organization for Nuclear Research)
Photoreceptor and optogenetics research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon